Restricted accessResearch articleFirst published online 2010-08
Comparative Study of Methylene Blue and Erythrosine Dyes Employed in Photodynamic Therapy for Inactivation of Planktonic and Biofilm-Cultivated Aggregatibacter actinomycetemcomitans
Aim: The proposal of this work was to test the efficacy of photodynamic therapy (PDT) by using methylene blue (MB) and erythrosine (ERY) to inactivate Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), the main pathogen in aggressive periodontitis. Methods:A. actinomycetemcomitans was cultivated in planktonic cultures and biofilm by using Tryptic Soy Broth medium. The sensibility (dark toxicity) to MB and ERY was determined, and its ideal concentration for PDT protocols was established. An odontologic resin photopolymerizer was used as the light source. The bacterial viability was determined by CFU (planktonic cultures) and microscopic observation (biofilms). Results: The results show that ERY is more efficient at killing bacterial cells of A. actinomycetemcomitans in planktonic (75%) and biofilm (77%) culture compared with MB (50% and 54%, respectively). Conclusion: PDT using MB or ERY as a photosensitizing agent and odontologic resin photopolymerizer as a light source could be an efficient option for pocket decontamination in aggressive periodontal disease.
Get full access to this article
View all access options for this article.
References
1.
GomerC.J., RuckerN., FerrarioA., WongS.1989. Properties and applications of photodynamic therapy. Radiat. Res., 120:1–18.
2.
HendersonB.W., DoughertT.J.1992. How does photodynamic therapy work?Photochem. Photobiol., 55:145–157.
PaulinoT.P., MagalhãesP.P., ThedeiG.Jr., TedescoA.C., CiancagliniP.2005. Use of visible light-based photodynamic therapy to bacterial photoinactivation. Biochem. Mol. Biol. Educ., 33:46–49.
5.
PaulinoT.P., RibeiroK.F., ThedeiG.Jr., TedescoA.C., CiancagliniP.2005. Use of hand held photopolymerizer to photoinactivate Streptococcus mutans. Arch. Oral. Biol., 50:353–359.
6.
MeiselP, KocherT.2005. Photodynamic therapy for periodontal disease: state of the art. J. Photochem. Photobiol. B., 79:159–170.
7.
WoodS., MetcalfD., DevineD., RobinsonC.2006. Erythosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother., 57:680–684.
8.
OliveiraR.R., Schwartz-FilhoH.O., NovaesA.B.J., TabaM.2007. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: a preliminary randomized controlled clinical study. J. Periodontol., 78:965–973.
9.
PeloiL.S., SoaresR.R.S., BiondoC.E.G.et al.2008. Photodynamic effect of light-emitting diode light on cell growth inhibition induced by methylene blue. J. Biosci., 33:231–237.
10.
PlaetzerK., KramerB., BerlandaJ., BerrF., KiesslichT.2009. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Laser Med. Sci., 24:259–268.
11.
PratesR.A., YamadaA.M.Jr., SuzukiL.C.et al.2007. Bacterial effect of malachite green and red laser on Aggregatibacter actinomycetemcomitans. J. Photochem. Photobiol. B., 86:70–76.
12.
TuiteE.M., KellyJ.M.1993. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J. Photochem. Photobiol. B., 21:103–124.
13.
UsachevaM.N., TeichertM.C., BielM.A.2001. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Laser Surg. Med., 29:165–173.
14.
SharmanW.M., AllenC.M., Van LierJ.E.1999. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today., 11:507–517.
15.
BegueW.J., BardR.C., KoehneG.W.1966. Microbial inhibition by erythrosinee. J. Dent Res., 45:1464–1467.
16.
GoulartR.C., BoleanM., PaulinoT.P.et al.2009. Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomycetemcomitans. Photomed. Laser Surg.10.1089/pho.2009.2591.
17.
SzeimiesR.M., DragerJ., AbelsC., LandthalerM.2001. History of photodynamic therapy in dermatology. Calzavara-PintonPG, SzeimiesRM, OrtelB. Photodynamic Therapy and Fluorescence Diagnosis in Dermatology. Amsterdam: Elsevier, 3–16.
18.
BowyerJ.D., HolroydC., ChandnaA.2007. The use of the fluorescein disappearance test in the management of childhood epiphora. Orbit, 20:181–187.
19.
PaczkowskiJ., LambertsJ.J., PaczkowskaB., NeckersD.C.1985. Photophysical properties of rose bengal and its derivatives (XII)J. Free Radic. Biol. Med., 1:341–351.
20.
SieberF., SpivakJ.L., SutcliffeA.M.1984. Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc. Natl. Acad. Sci. U S A., 81:7584–7587.
21.
KaplanJ.B., MeyenhoferM.F., FineD.H.2003. Biofilm growth and detachment of Actinobacillus actinomycetemcomitans. J Bacteriol., 185:1399–1404.
22.
SoukosN.S., WilsonM., BurnsT., SpeightP.M.1996. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblast and Streptococcus sanguis evaluated in vitro. Lasers Surg. Med., 18:253–259.
23.
AghahosseiniF., Arbabi-KalatiF., FashtamiL.A., FatehM., DjavidGE.2006. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Med. Oral Pathol. Oral. Circ. Bucal., 11:E126–EI29.
24.
ChanY., LaiC.H.2003. Bacterial effects of different laser wavelengths on periodontopathic germs in photodynamic therapy. Laser Med., 18:51–55.
25.
RickardA.H., GilbertP., HigtN.J., KolenbranderP.E., HandleyP.S.2003. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol., 11:94–100.
26.
LunardiC.N., TedescoA.C.2005. Synergic photosensitizers: a new trend in photodynamic therapy. Curr. Org. Chem., 9:813–821.
27.
MetcalfD., RobisonC., DevineD, WoodS. 2006. Enhancement of erythrosinee-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J. Antimicrob. Chemother., 58:190–192.
